A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats

Experimental Neurology

Volumn 226, Issue 1, 2010, Pages 231-241

  Solbrig, Marylou V ^a   Fan, Yijun ^a   Hermanowicz, Neal ^b   Morgese, Maria Grazia ^c   Giuffrida, Andrea ^d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FOGGIA   (Italy)

^d University of Texas Health Science Center   (United States)

Author keywords

Anandamide; Borna disease virus; BrdU; Endocannabinoid; Neurogenesis; WIN55,212 2

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; ANTIMETABOLITE; BENZOXAZINE DERIVATIVE; BROXURIDINE; CANNABINOID; CANNABINOID RECEPTOR AFFECTING AGENT; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORNA DISEASE VIRUS; BRAIN LEVEL; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; DEMYELINATING DISEASE; DRUG MECHANISM; INFLAMMATION; MACROPHAGE; MALE; MICROGLIA; NERVE CELL DIFFERENTIATION; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STEM CELL; VIRUS ENCEPHALITIS; ANIMAL; CELL COUNT; CELL DIFFERENTIATION; DIAGNOSTIC USE; DRUG EFFECTS; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; LEWIS RAT; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY;

ANIMALS; ANTIMETABOLITES; BENZOXAZINES; BORNA DISEASE VIRUS; BROMODEOXYURIDINE; CANNABINOIDS; CELL COUNT; CELL DIFFERENTIATION; CELL SURVIVAL; ENCEPHALITIS, VIRAL; ENDOCANNABINOIDS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MORPHOLINES; NAPHTHALENES; NEOVASCULARIZATION, PATHOLOGIC; NEUROGENESIS; OLIGODENDROGLIA; RATS; RATS, INBRED LEW; STEM CELLS; CANNABINOID RECEPTOR MODULATORS;

EID: 77957802792     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.09.003     Document Type: Article

References (89)

1. Aguado T., Monory K., Palazuelos J., Stella N., Cravatt B., Lutz B., Marsicano G., Kokaia Z., Guzman M., Galve-Roperh I. The endocannabinoid system drives neural progenitor proliferation. FASEB J. 2005, 19:1704-1706.
2. Aguado T., Palazuelos J., Monory K., Stella N., Cravatt B., Lutz B., Marsicano G., Kokaia Z., Guzman M., Galve-Roperh I. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J. Neurosci. 2006, 26:551-561.
3. Alvarez-Buylla A., Lim D.A. For the long run: maintaining germinal niches in the adult brain. Neuron 2004, 41:683-686.
4. Aponso P.M., Faull R.L.M., Connor B. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease. Neuroscience 2008, 151:1142-1153.
5. Archbald S.L., Masliah E., Fennema-Notestine C., Marcotte T.D., Ellis R.J., McCutchan J.A., Heataon R.K., Grant I., Mallory M., Miller A., Jernigan T.L. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch. Neurol. 2004, 61:369-376.
6. Arevalo-Martin A., Vela J.M., Molina-Holgadao E., Borrell J., Guaza C. Therapeutic actions of cannabinoids in a murine model of multiple sclerosis. J. Neurosci. 2003, 23:2511-2516.
7. Arevalo-Martin A., Garcia-Ovejero D., Rubio Araiz A., Gomex O., Molina-Holgado F., Molina-Holgado E. Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2. Eur. J. Neurosci. 2007, 26:1548-1559.
8. Aylward E.H., Henderer J.D., McArthur J.C., Brettschneider P.D., Harris G.J., Barta P.E., Pearlson G.D. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 1993, 43:2099-2104.
9. Bancroft J.D., Stevens A. Theory and Practice of Histological Techniques 1996, Churchill Livingstone, Edinburgh.
10. Benito C., Kim W.K., Chavarria I., Hillard C.J., Mackie K., Tolon R.M., Williams K., Romero J. A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. J. Neurosci. 2005, 25:2530-2536.
11. Cabranes A., Venderova K., de Lago E., Fezza F., Sanchez A., Mestre L., Valenti M., Garcia-Merino A., Ramos J.A., Di Marzo V., Fernandez-Ruiz J. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Neurobiol. Dis. 2005, 20:207-217.
12. Carbone K.M., Trapp B.D., Griffin J.W., Duchala C.S., Narayan O. Astrocytes and Schwann cells are virus-host cells in the nervous system of rats with Borna disease. J. Neuropathol. Exp. Neurol. 1989, 48:631-644.
13. Carbone K.M., Moench T.R., Lipkin W.I. Borna disease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: location of viral genomic and messenger RNAs by in situ hybridization. J. Neuropathol. Exp. Neurol. 1991, 50:205-214.
14. Castelli M.P., Paola Piras A., D'Agostino A., Pibiri F., Perra S., Gessa G.L., Maccarrone M., Psitis M. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. Eur. J. Pharmacol. 2007, 573:11-19.
15. Cencioni M.T., Chiurchiu V., Catanzaro G., Borsellino G., Bernardi G., Battistini L., Maccarrone M. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS ONE 2010, 5:e8688.
16. Chang L., Speck O., Miller E.N., Braun J., Jovicich J., Koch C., Itti L., Ernst T. Neural correlates of attention and working memory deficits in HIV patients. Neurology 2001, 57:1001-1007.
17. Clemente R., de Parseval A., Perez M., de al Torre J.C. Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry. J. Virol. 2009, 83:2655-2662.
18. Clemente R., Sisman E., Aza-Blanc P., de al Torre J.C. Identification of host factors involved in Borna disease virus cell entry through a siRNA functional genetic screen. J. Virol. 2010, 84:3562-3575.
19. Croxford J.L., Miller S.D. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212. J. Clin. Invest. 2003, 111:1231-1240.
20. Dayer A.G., Cleaver K.M., Abouantoun T., Cameron H.A. New GABAergic interneurons in the adult neocortex and striatum are generated from different precursors. J. Cell Biol. 2005, 168:415-427.
21. Deschl U., Stitzs L., Herzog S., Frese K., Rott R. Determination of immune cells and expression of major histocompatibility complex class II antigen in encephalitic lesions of experimental Borna disease. Acta Neuropathol. 1990, 81:41-50.
22. Deuschle M., Bode L., Heuser I., Schmider J., Ludwig H. Borna disease virus proteins in cerebrospinal fluid of patients with recurrent depression and multiple sclerosis. Lancet 1998, 352:1828-1829.
23. Di Marzo V., Berrendero F., Bisogno T., Gonzalez S., Cavaliere P., Romero J., Cebeira M., Ramos J.A., Fernandez-Ruiz J.J. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of depta9-tetrahydrocannabinol-tolerant rats. J. Neurochem. 2000, 74:1627-1635.
24. Dias-Ferreira E., Sousa J.C., Melo I., Morgado P., Mesquita A.R., Cerqueira J.J., Costa R.M., Sousa N. Chronic stress causes frontostriatal reorganization and affects decision-making. Science 2009, 325:621-625.
25. Duan X., Kang E., Liu C., Ming G.-I., Song H. Developmnet of neural stem cell in the adult brain. Curr. Opin. Neurobiol. 2008, 18:108-115.
26. Gabbott P.L., Warner T.A., Jays P.R., Salway P., Busby S.J. Prefrontal cortex in the rat: projections to subcortical autonomic, motor and limbic centers. J. Comp. Neurol. 2005, 492:145-177.
27. Gage F. Mammalian neural stem cells. Science 2000, 287:1433-1438.
28. Galve-Roperh I., Aquado T., Palazuelos J., Guzman M. The endocannabinoid system and neurogenesis in health and disease. Neuroscientist 2007, 13:109-114.
29. Galve-Roperh I., Aquado T., Palazuelos J., Guzman M. Mechanisms of control of neuron survival by the endocannabinoid system. Curr. Pharm. Des. 2008, 14:2279-2288.
30. Gonzalez-Dunia D., Watanabe M., Syan S., Mallory M., Masliah E., de la Torre J.C. Synaptic pathology in Borna disease virus persistent infection. J. Virol. 2000, 74:3441-3448.
31. Gosztonyi G., Ludwig H. Borna disease-neuropathology and pathogenesis. Curr. Top. Microbiol. Immunol. 1995, 190:39-73.
32. Hardison S., Weintraub S.T., Giuffrida A. Quantification of endocannabinoids in rat biological samples by GC/MS: technical and theoretical considerations. Prostaglandins Other Lipid Mediat. 2006, 81:106-112.
33. Harkany T., Guzman M., Galve-Roperh I., Berguis P., Devi L.A., Mackie K. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol. Sci. 2007, 28:83-92.
34. Hatalski C.G., Hickey W.F., Lipkin W.I. Evolution of the immune response in the central nervous system following infection with Borna disease virus. J. Neuroimmunol. 1998, 90:137-142.
35. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 1990, 87:1932-1936.
36. Jiang W., Zhang Y., Xiao L., Van Cleemput J., Ji S.P., Bai G., Zhang X. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J. Clin. Invest. 2005, 115:3104-3116.
37. Jordan I., Briese T., Averatt D.R., Lipkin W.I. Inhibition of Borna disease virus replication by ribavirin. J. Virol. 1999, 73:7903-7906.
38. Klein T.W., Newton C., Larsen K., Lu L., Perkins I., Nong L., Friedman H. The cannabinoid system and immune modulation. J. Leukoc. Biol. 2003, 74:486-496.
39. Krathwohl M.D., Kaiser J.L. HIV-1 promotes quiescence in human neural progenitor cells. J. Infect. Dis. 2004, 190:216-226.
40. Kuhn H.G., Dickinson-Anson H., Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci. 1996, 16:2027-2033.
41. Leung P.S., Shu S.A., Kenny T.P., Wu P.Y., Tao M.H. Development and validation of gene therapies in autoimmune diseases: epidemiology to animal models. Autoimmun. Rev. 2010, 9:A400-A405.
42. Loria F., Petrosino S., Mestre L., Spagnolo A., Correa F., Hernangomez M., Guaza C., DiMarzo V., Docagne F. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide. Eur. J. Neurosci. 2008, 28:633-641.
43. Loria F., Petrosino S., Hernangomez M., Mestre L., Spagnolo A., Correa F., Di Marzo V., Docagne F., Guaza C. An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis. Neurobiol. Dis. 2010, 37:166-176.
44. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetti C., Bernardi G., Finazzi-Agro A., Cravatt B.F., Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglyceral in the striatum. Nat. Neurosci. 2008, 11:152-159.
45. Maccarrone M., De Chiara V., Gasperi V., Viscomi M.T., Rossi S., Oddi S., Molinari M., Musella A., Finazzi-Agro A., Centonze D. Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum. J. Neurochem. 2009, 109:371-381.
46. Mandyam C.D., Wee S., Eisch A.J., Richardson H.N., Koob G.F. Methamphetamine self-administration and voluntary exercise have opposing effects on medial prefrontal cortex gliogenesis. J. Neurosci. 2007, 27:11442-11450.
47. Mao L., Wang J.Q. Gliogenesis in the striatum of the adult rat: alteration in neural progenitor population after psychostimulant exposure. Brain Res. Dev. Brain Res. 2001, 130:41-51.
48. Marchalant Y., Brothers H.M., Norman G.J., Karelina K., DeVries A.C., Wenk G.L. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. Neurobiol. Dis. 2009, 34:300-307.
49. Maresz K., Pryce G., Ponomarev E.D., Marsicano G., Croxford J.L., Shriver L.P., Ledent C., Cheng X., Carrier E.J., Mann M.K., Giovannoni G., Pertwee R.G., Yamamura T., Buckley N.E., Hillard C.J., Lutz B., Baker D., Dittel B.N. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat. Med. 2007, 13:492-497.
50. McCombe J.A., Auer R.N., Maingat F.G., Houston S., Gill M.J., Power C. Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS. Neurology 2009, 73:835-841.
51. Melrose R.J., Tinaz S., Castelo J.M., Coutney M.G., Stern C.E. Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behav. Brain Res. 2008, 188:337-347.
52. Mestre L., Correa F., Arevalo-Martin A., Molina-Holgado E., Valenti M., Ortar G., Di Marzo V., Guaza C. Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. J. Neurochem. 2005, 92:1327-1339.
53. Mestre L., Docagne F., Correa F., Loria F., Hernangomez M., Borrell J., Guaza C. A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. Mol. Cell. Neurosci. 2009, 40:258-266.
54. Miller A.M., Stella N. CB2 receptor-mediated migration of immune cells: it can go either way. Br. J. Pharmacol. 2008, 153:299-308.
55. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., Katz-Levy Y., Carrizosa A., Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997, 3:1133-1136.
56. Molina-Holgado E., Vela J.M., Arevalo-Martin A., Almazan G., Molina-Holgado F., Borrell J., Guaza C. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J. Neurosci. 2002, 23:2511-2516.
57. Ni X., Geller E.B., Eppihimer M.J., Eisenstein T.K., Adler M.W., Tuma R.F. Win 55,212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model. Mult. Scler. 2004, 10:158-164.
58. Nishiyama A., Komitova M., Suzuki R., Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat. Rev. Neurosci. 2009, 10:9-22.
59. Nones J., Spohr T.C., Furtado D.R., Sartore R.C., Paulsen B.S., Guimaraes M.Z., Rehen S.K. Cannabinoids modulate cell survival in embryoid bodies. Cell Biol. Int. 2010, 34:399-408.
60. Ortega-Gultierrez S., Molina-Holgado E., Arevalo-Martin A., Correa F., Viso A., Lopez-Rodriguez M.L., DeMarzo V., Guaza C. Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis. FASEB J. 2005, 19:1338-1340.
61. Ovanesov M.V., Sauder C., Rubin S.A., Richt J., Nath A.M., Carbone K.M., Pletnikov M.V. Activation of microglia by Borna disease virus infection: in vitro study. J. Virol. 2006, 80:12141-12148.
62. Palazuelos J., Davoust N., Julien B., Hatterer E., Aguado T., Mechoulam R., Benito C., Romero J., Silva A., Guzman M., Nataf S., Galve-Roperh I. The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. J. Biol. Chem. 2008, 283:13320-13329.
63. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego. fourth edition.
64. Peng H., Whitney N., Wu Y., Tian C., Dou H., Zhou Y., Zheng J. HIV-1-infected and/or immune-activated macrophage-secreted TNF-alpha affects human fetal cortical neural progenitor cell proliferation and differentiation. Glia 2008, 56:903-916.
65. Planz O., Stitz L. Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response. J. Virol. 1999, 73:1715-1718.
66. Price D.A., Martinez A.A., Seillier A., Koek W., Acosta Y., Fernandez E., Strong R., Lutz B., Marsicano G., Roberts J.L., Giuffrida A. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Eur. J. Neurosci. 2009, 29:2177-2186.
67. Pryce G., Ahmed Z., Hankey D.J., Jackson S.J., Croxford J.L., Pocock J.M., Ledent C., Petzold A., Thompson A.J., Giovannoni G., Cuzner M.L., Baker D. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 2003, 126:2191-2202.
68. Sanchez A.J., Gonzalez-Perez P., Galve-Roperh I., Garcia-Merino A. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor. Biochem. Pharmacol. 2006, 72:1697-1706.
69. Schley M., Stander S., Kerner J., Vajkoczy P., Schupfer G., Dusch M., Schmelz M., Konrad C. Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans. Brain Res. Bull. 2009, 79:333-337.
70. Schwartz L., Civitello L., Dunn-Pirio A., Ryschkewitsch S., Berry E., Cavert W., Kinzel N., Lawrence D.M., Hazra R., Major E.O. Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue. J. Neurovirol. 2007, 13:274-283.
71. Shapiro L.A., Ng K.L., Kinyamu R., Whitaker-Azmitia P., Geisert E.E., Blurton-Jones M., Zhou Q.-Y., Ribak C.E. Origin, migration and fate of newly generated neurons in the adult rodent piriform cortex. Brain Struct. Funct. 2007, 212:133-148.
72. Solbrig M.V., Hermanowicz N. Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats. J. Neurovirol. 2008, 14:5191-5194.
73. Solbrig M.V., Koob G.F., Fallon J.H., Lipkin W.I. Tardive dyskinetic syndrome in rats infected with Borna disease virus. Neurobiol. Dis. 1994, 1:111-119.
74. Solbrig M.V., Koob G.F., Fallon J.H., Reid S., Lipkin W.I. Prefrontal cortex dysfunction in Borna disease virus (BDV)-infected rats. Biol. Psychiatry 1996, 40:629-636.
75. Solbrig M.V., Koob G.F., Parsons L.H., Kadota T., Horscroft N., Briese T., Lipkin W.I. Neurotrophic factor expression after CNS viral injury produces enhanced sensitivity to psychostimulants: potential mechanism for addiction vulnerability. J. Neurosci. 2000, 20:RC104.
76. Solbrig M.V., Koob G.F., Lipkin W.I. Key role for enkephalinergic tone in cortico-striatal-thalamic function. Eur. J. Neurosci. 2002, 1819-1822.
77. Solbrig M.V., Schlaberg R., Briese T., Horscroft N., Lipkin W.I. Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats. Antimicrob. Agents Chemother. 2002, 46:2287-2291.
78. Solbrig M.V., Adrian R., Baratta J., Piomelli D., Giuffrida A. A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. Exp. Neurol. 2005, 194:355-362.
79. Solbrig M.V., Adrian R., Baratta J., Lauterborn J.C., Koob G.F. Kappa opioid control of seizures produced by a virus in an animal model. Brain 2006, 129:642-654.
80. Stella N. Endocannabinoid signaling in microglial cells. Neuropharmacology 2009, 56(Suppl 1):244-253.
81. Stitz L., Biltzer T., Planz O. The immunopathogenesis of Borna disease virus infection. Front. Biosci. 2002, 7:d541-d555.
82. Stout J.C., Ellis R.J., Jernigan T.L., Archbald S.L., Abramson I., Worlfson T., McCutchan J.A., Wallace M.R., Atkinson J.H., Grant I. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch. Neurol. 1998, 55:161-168.
83. Thompson P.M., Dutton R.A., Hayashi K.M., Toga A.W., Lopez O.L., Aizenstein H.J., Becker J.T. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc. Natl. Acad. Sci. USA 2005, 102:15647-15652.
84. Tompkins S.M., Fuller K.G., Miller S.D. Theiler's virus-mediated autoimmunity: local presentation of CNS antigens and epitope spreading. Ann. NY Acad. Sci. 2002, 958:26-38.
85. Uchigashima M., Nanushima M., Fukaya M., Katona I., Kano M., Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 2007, 27:3663-3676.
86. Van Marle G., Anthony J.M., Silva C., Sullivan A., Power C. Aberrant cortical neurogenesis in a pediatric neuroAIDS model: neurotrophic effects of growth hormone. AIDS 2005, 19:1781-1791.
87. Velasco G., Carracedo A., Blazquez C., Lorente M., Aguado T., Haro A., Sanchez C., Galve-Roperh I., Guzman M. Cannabinoids and gliomas. Mol. Neurobiol. 2007, 36:60-67.
88. Wolf S.A., Tauber S., Ullrich O. CNS immune surveillance and neuroinflammation: endocannabinoids keep control. Curr. Pharm. Des. 2008, 14:2266-2278.
89. Yamada M., Zurbriggen A., Fujinami R.S. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J. Exp. Med. 1990, 171:1893-1907.